TIM3 gene polymorphisms in patients with chronic hepatitis B virus infection: impact on disease susceptibility and hepatocellular carcinoma traits

Tissue Antigens
Z LiF Li

Abstract

Hepatitis B virus (HBV) infection is associated with the development of acute and chronic liver diseases including hepatocellular carcinoma (HCC). T-cell immunoglobulin domain and mucin domain-containing molecule-3 (Tim-3), which negatively regulates T-cell response and mediates phagocytosis of apoptotic cells, has been implicated in HBV infection and cancers. This study explored the polymorphisms of TIM3 gene in 535 patients with HBV-related liver diseases including 213 chronic hepatitis, 178 cirrhosis and 144 HCC, 72 HBV infection resolvers and 182 healthy controls and analyzed the effects of these polymorphisms on the disease susceptibility and HCC traits. TIM3-1541C/T, -1516G/T, -882C/T, -574G/T and +4259T/G polymorphisms were genotyped using polymerase chain reaction-restriction fragment length polymorphism. Of the five polymorphisms genotyped, the allele T-containing genotypes (GT + TT), allele T and allele T-containing haplotype (CTCGT) of -1516G/T polymorphism were more frequent in HBV patients than in controls [P = 0.005, odds ratio (OR) = 2.300, 95% confidence interval (CI): 1.294-4.088; P = 0.004, OR = 2.266, 95% CI: 1.297-3.962; and P = 0.005, OR = 2.203, 95% CI: 1.260-3.854, respectively]. The allele T-containing g...Continue Reading

References

Jul 24, 2004·Experimental & Molecular Medicine·Soo-Cheon ChaeHun-Taeg Chung
Nov 16, 2005·Nature Immunology·Chen ZhuVijay K Kuchroo
Apr 11, 2008·Journal of Human Genetics·Patrick BrückKlaus Badenhoop
Dec 5, 2008·The New England Journal of Medicine·Ching-Lung Lai, Man-Fung Yuen
May 12, 2009·Immunological Reviews·Roselynn Rodriguez-ManzanetDale T Umetsu
Jul 2, 2009·BMC Medical Genetics·Jian ZhangAndrew J Sandford
Jan 20, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·Rosemarie H DeKruyffJosé M Casasnovas
Jun 12, 2010·Immunological Reviews·Gordon J FreemanRosemarie H DeKruyff
Sep 3, 2010·Cancer Immunology, Immunotherapy : CII·Bangwei CaoShutian Zhang
Sep 8, 2010·The Journal of Experimental Medicine·Kaori SakuishiAna C Anderson
Mar 2, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Anna SchurichMala K Maini

❮ Previous
Next ❯

Citations

Oct 6, 2012·The Tohoku Journal of Experimental Medicine·Hiroki SaitohToshio Hattori
Aug 25, 2015·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·Hong PengJin-Jun Guo
Jan 8, 2013·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·Zhu LiZhengwen Liu
May 28, 2016·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·J P PeiK Jing
Jul 14, 2017·International Journal of Molecular Sciences·Hyosun ChoChang Wook Kim
Apr 9, 2016·World Journal of Hepatology·Shilu MathewIshtiaq Qadri
Oct 13, 2018·Journal of Hematology & Oncology·Feifei LiuZhi Chen
Feb 24, 2016·World Journal of Gastroenterology : WJG·Yuan LiuChun-Hong Ma
Feb 2, 2021·Frontiers in Immunology·Marta WagnerLidia Karabon
Feb 23, 2021·Frontiers in Oncology·Ying TangDa-Yong Zheng

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.